The Readout Loud cover image

321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target

The Readout Loud

00:00

Navigating Trials and Treatments in Obesity

This chapter analyzes Recursion's clinical trial results and their influence on investor sentiment while exploring the evolving landscape of obesity treatments, particularly focusing on amylin. It also discusses the challenges faced by Amylin Pharmaceuticals and highlights promising developments from Zealand that may enhance patient outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app